Precision Medicine Market Size, Share, Trends | Opportunities, Demands and Growth Revenue by 2026 | Brandessence Market Research Report

The MarketWatch News Department was not involved in the creation of this content.

Dec 03, 2020 (Heraldkeepers) —
The Precision Medicine Market delivers a succinct analysis on industry size, regional growth and revenue forecasts for the upcoming years. The report further sheds light on significant challenges and latest growth strategies adopted by manufacturers who are a part of the competitive spectrum of this business domain.

Precision Medicine Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2020-2025. The growth in the precision medicine market is propelled by an increasing demand for personalized treatment; technological innovation and advancement , as well as growth of personal healthcare devices are major key factor which drives the Global Precision Medicine Market.

Get Sample Copy of This Premium Report https://brandessenceresearch.com/requestSample/PostId/55

**The sample pages of this report is immediately accessible on-demand.**

Top Precision Medicine companies:

key strategies followed by the top players operating in the precision medicine market are,

  • Abbott Laboratories
  • GE Healthcare
  • GlaxoSmithKline (GSK)
  • Johnson & Johnson
  • Pfizer
  • Laboratories Corporation of America Holdings
  • Danaher Corporation
  • Biocrates Life Sciences AG
  • Nanostring Technologies
  • Intomics
  • Ferrer Incode
  • Eagle Genomics Ltd

Scope of Market Reports –

Precision medicine is often called as Personalized Medicine. It is used to describe how genetic information about a person’s disease is being used to diagnose or treat their disease. Precision Medicine refers to the modification of medical treatment to the individual characteristics of each patient. It does not exactly mean the manufacturing of drugs or medical devices that are unique to a patient, but the ability to categorize individuals into sub-populations that diverge in their susceptibility to a particular disease. Preventive or therapeutic interventions can then be focused on those who will benefit, sparing cost and side effects for those who will not. The main aim of government regulations is to make Precision Medicines more accepted and it is focused towards genetic diseases related to oncology, skin, respiratory, central nervous system, cardiovascular, and infectious diseases.

The key objective of Cancergenomics is to improve personalized medicine through the DNA sequencing and analysis of patient tumors cells to find out new genetic mutation associated with specific cancers.

Genetic information has helped to increase the development and use of the newest cancer treatments like Chemotherapy, Radiation Therapy, Targeted Therapy and Precision Medicines. For example, the drug Imatinib was modified to inhibit an altered enzyme produced by a fused version of two genes found in chronic myelogenousleukemia. Another example is the breast cancer drug Trastuzumab which works only for women whose tumors have a particular genetic profile calledHuman Epidermal Growth Factor Receptor 2(HER-2 positive). It is also found that lung cancer patients whose tumors are positive forEstimated Glomerular Filtration Rate (EGFR)mutations will respond to the drugs Gefitinib and Erlotinib which target this mutation. Conversely, colon cancer patients whose tumors have a mutation in a gene called KRAS (K-RAS) derive less benefit from the drugs Cetuximab and Panitumumab. The genomic information made by The Cancer Genome Atlas (TCGA) will boostthe research to develop similar treatment strategies for

Read more

Sports Medicine Market Analysis by Applications, End-Users, Top Companies, Future Growth Opportunities, Product Type, Global Forecast To 2020

The MarketWatch News Department was not involved in the creation of this content.

Japan, Japan, Wed, 02 Dec 2020 14:20:31 / Comserve Inc. / — Over the years, the sports medicine market has witnessed various technological advancements made to ensure and provide better recovery and rehabilitative measures for injuries caused during sports or physical activities.

The sports medicine market comprises products and devices used by professional or non-professional athletes or sportspersons to prevent and protect themselves from injuries as well as devices that enhance performance. The sports medicine products play an important role in the rehabilitation, recovery, protection, endurance, and monitoring of athletes while playing sports. Over the years, the sports medicine market has witnessed various technological advancements made to ensure and provide better recovery and rehabilitative measures for injuries caused during sports or physical activities.

These advancements have led to the development of new products and therapies to treat sports injuries. Various market players are focusing on the introduction of newer products and treatment options for sports injuries. A number of key players are competing to secure larger shares of the market by launching new products. Arthrex, Inc. (U.S.), Smith & Nephew PLC (U.K.), DePuy Synthes Companies (U.S.), Stryker Corporation (U.S.), and CONMED Corporation (U.S.) are the top five players of this market

Request to Fill The Form To get Sample Copy of This Report: https://www.sdki.jp/sample-request-61031

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global And Regional Market).”

In 2015, the body reconstruction & repair products segment is expected to account for the largest share of the global sports medicine market, by product, while the knee injuries segment is expected to account for the largest share of the sports medicine market, by application.

In 2015, North America is expected to account for the largest share of the global sports medicine market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). In the coming years, the sports medicine market is expected to witness the highest growth rate in the Asia-Pacific region, with emphasis on India, China, and Japan. The entry of international players, increasing government initiatives, and rising awareness regarding sports medicine in emerging nations like India and China are expected to drive the market in these regions.

The sports medicine market witnesses high competitive intensity as there are several big and many small firms with similar product offerings. These companies adopt various growth strategies (agreements, partnerships, joint ventures, geographic expansions, new product launches, and acquisitions) to increase their market shares and establish a strong foothold in the global market.

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global And Regional Market).”

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market

Read more

Regenerative Medicine Market measure with Report In Depth Industry Analysis on Trends, Growth, Opportunities and Forecast till 2026

The MarketWatch News Department was not involved in the creation of this content.

Dec 02, 2020 (Market Insight Reports) —
The latest report on ‘Regenerative Medicine market’ collated by Market Study Report, LLC, delivers facts and numbers regarding the market size, geographical landscape and profit forecast of the ‘Regenerative Medicine market’. In addition, the report focuses on major obstacles and the latest growth plans adopted by leading companies in this business.

Request a sample Report of Regenerative Medicine Market at: https://www.marketstudyreport.com/request-a-sample/1695290?utm_source=marketwatch&utm_medium=RV

The Regenerative Medicine Market is anticipated to reach over USD 79.23 billion by 2026 according to a new research. In 2017, the cell therapy dominated the global Regenerative Medicine market, in terms of revenue. North America is expected to be the leading contributor to the global market revenue in 2017.

The regenerative medicine market is primarily driven by the increasing number of individuals suffering from cancer, rising need to monitor and treating these chronic diseases in the limited time. Furthermore, stringent government policies, proper reimbursement policies, and increasing government healthcare expenditure for developing healthcare infrastructure to also boost the market growth in coming years. Also, rising number of organ transplantation, and increasing number of products in pipeline that are waiting for approval create major opportunity for the regenerative medicines in the coming years. However, some of the ethical and religious concerns for the use of stem cells, and lack of proper regulatory for the approval of various drugs would impede the market growth during the forecast period.

Enquiry about Regenerative Medicine market report before Buying at: https://www.marketstudyreport.com/enquiry-before-buying/1695290?utm_source=marketwatch&utm_medium=RV

North America generated the highest revenue in the Regenerative Medicine market in 2017, and is expected to be the leading region globally during the forecast period. Increasing number of patients suffering from chronic diseases, improved healthcare infrastructure and health facilities, accessibility of healthcare facilities, are the primary factors driving the market growth in this region. While, Asia Pacific to be the fastest growing region in the coming years. The growth in this region is majorly attributed to the developing healthcare infrastructure of the countries like India, & China, and rising awareness for the use of regenerative medicines as an effective treatment option for chronic diseases.

Regenerative medicine is a branch of medicine that regrows, and repairs the damaged cells in the human body. These medicines include the use of stem cells, tissue engineering, that further helps in developing new organ that function smoothly. These medicines have the caliber of developing an entire organ as these cells are multipotent. The cells are majorly isolated from bone marrow, and umbilical cord blood.

Purchase full report of Regenerative Medicine market at: https://www.marketstudyreport.com/securecheckout/paymenta/1695290?utm_source=marketwatch&utm_medium=RV?msfpaycode=sumsf

The key players operating in the Regenerative Medicine market include Organogenesis Inc., Vericel Corporation, Osiris Therapeutics, Inc., Stryker Corporation, and NuVasive, Inc., Medtronic Plc., Acelity, Cook Biotech Inc., Integra LifeSciences, and C.R. Bard. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

Regenerative Medicine Market share

Read more

Personalized Medicine Market 2020 Research Report by Size, Revenue, Opportunities, COVID-19 Impact, Status and Outlook to 2024 | Absolute Reports

The MarketWatch News Department was not involved in the creation of this content.

Dec 02, 2020 (The Expresswire) —
“Final Report will add the analysis of the impact of COVID-19 on this industry.”

Global “Personalized Medicine Market” forecast 2020-2024 is a historical overview and in-depth study on the present and upcoming market of the Personalized Medicine industry. The report represents a basic overview of the Personalized Medicine market size, share, and competitor segment with a basic introduction of manufactures, geographical regions, product types, and applications. This report gives a historical overview of the Personalized Medicine market trends, growth, revenue, capacity, cost structure, and key driver’s analysis.

About Personalized Medicine:

Individualized medication, medication “vary from person to person” , give full consideration to each patient’s genetic factors, gender, age, body weight, physiological and pathological characteristics, and are taking other drugs on the basis of the comprehensive situation of safe, reasonable, effective and economic drug treatment.

Get a Sample Copy of the Report – https://www.absolutereports.com/enquiry/request-sample/14684359

Personalized Medicine Market Segment by Manufacturers, this report covers:

● Abbott Laboratories ● Agilent Technologies ● Amgen ● Astellas Pharma ● Astrazeneca ● Bayer AG ● Celgene Corporation ● Glaxosmithkline Plc ● Illumina ● Johnson and Johnson ● Laboratory Corporation ● Merck ● Novartis AG ● Roche Holding AG ● Siemens AG ● Takeda Pharmaceutical Company Limited

Market Segment by Regions, regional analysis covers:

● North America (United States, Canada and Mexico) ● Europe (Germany, France, UK, Russia and Italy) ● Asia-Pacific (China, Japan, Korea, India and Southeast Asia) ● South America (Brazil, Argentina, Colombia etc.) ● Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers:

● Personalized Medicine Diagnostics ● Personalized Medical Care ● Personalized Medicine Therapeutics ● Personalized Nutrition and Wellness

Market Segment by Applications, can be divided into:

● Oncology ● Central Nervous System (CNS) ● Immunology ● Respiratory ● Other Applications ● Personalized MedicinePersonalized Medicine

To Understand How Covid-19 Impact Is Covered in This Report – https://www.absolutereports.com/enquiry/request-covid19/14684359

Scope of this report:

● The global Personalized Medicine market is expected to reach significant USD by the end of 2024. ● The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. ● North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Personalized Medicine. ● Europe also play important roles in global market, with market size of significant USD in 2019. ● This report studies the Personalized Medicine market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Personalized Medicine market by product type and applications/end industries.

The content of the study subjects includes a total of 15 chapters:

● Chapter 1, to describe Personalized Medicine product scope, market overview, market opportunities, market driving force and market

Read more

Regenerative Medicine Market 2020 Global Trends Evaluation, Geographical Segmentation, and Investment Opportunities till 2026

The MarketWatch News Department was not involved in the creation of this content.

Nov 25, 2020 (AmericaNewsHour) —
The Regenerative Medicine Market report provides an in-depth analysis of the Healthcare & Pharmaceuticals during the forecast period 2017-2026 which consists of the industry overview including the market size, volume, growth rate and recent trends and developments in the market based on historical and current data. The report covers detailed information about the key players, market segments, growth drivers and restraints in the industry. The report delivers an insight into the Regenerative Medicine Market which allows our clients to make informed decisions regarding the growth of their businesses.

The Regenerative Medicine Market is anticipated to reach over USD 79.23 billion by 2026 according to a new research published by Polaris Market Research. In 2017, the cell therapy dominated the global Regenerative Medicine market, in terms of revenue. North America is expected to be the leading contributor to the global market revenue in 2017.
Regenerative medicine is a branch of medicine that regrows, and repairs the damaged cells in the human body. These medicines include the use of stem cells, tissue engineering, that further helps in developing new organ that function smoothly. These medicines have the caliber of developing an entire organ as these cells are multipotent. The cells are majorly isolated from bone marrow, and umbilical cord blood.

Download free Sample of This Strategic Report:- https://www.kennethresearch.com/sample-request-10070801

The regenerative medicine market is primarily driven by the increasing number of individuals suffering from cancer, rising need to monitor and treating these chronic diseases in the limited time. Furthermore, stringent government policies, proper reimbursement policies, and increasing government healthcare expenditure for developing healthcare infrastructure to also boost the market growth in coming years. Also, rising number of organ transplantation, and increasing number of products in pipeline that are waiting for approval create major opportunity for the regenerative medicines in the coming years. However, some of the ethical and religious concerns for the use of stem cells, and lack of proper regulatory for the approval of various drugs would impede the market growth during the forecast period.

North America generated the highest revenue in the Regenerative Medicine market in 2017, and is expected to be the leading region globally during the forecast period. Increasing number of patients suffering from chronic diseases, improved healthcare infrastructure and health facilities, accessibility of healthcare facilities, are the primary factors driving the market growth in this region. While, Asia Pacific to be the fastest growing region in the coming years. The growth in this region is majorly attributed to the developing healthcare infrastructure of the countries like India, & China, and rising awareness for the use of regenerative medicines as an effective treatment option for chronic diseases.

The key players operating in the Regenerative Medicine market include Organogenesis Inc., Vericel Corporation, Osiris Therapeutics, Inc., Stryker Corporation, and NuVasive, Inc., Medtronic Plc., Acelity, Cook Biotech Inc., Integra LifeSciences, and C.R. Bard. These companies launch new products and collaborate with other market leaders

Read more

Global Regenerative Medicine Market 2020-2025: Opportunities with the Implementation of the 21st Century Cures Act

Dublin, Nov. 24, 2020 (GLOBE NEWSWIRE) — The “Regenerative Medicine Market by Product (Cell Therapies (Autologous, Allogenic), Stemcell Therapy, Tissue-engineering, Gene Therapy), Application (Wound Care, Musculoskeletal, Oncology, Dental, Ocular), Geography – Global Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering.

The Global Regenerative Medicine Market is Projected to Reach USD 17.9 Billion by 2025 from USD 8.5 Billion in 2020, at a CAGR of 15.9% during the Forecast Period.

Market growth is driven by the rising prevalence of chronic diseases, genetic disorders, and cancer; rising investments in regenerative medicine research; and the growing pipeline of regenerative medicine products. However, the high cost of cell and gene therapies and ethical concerns related to the use of embryonic stem cells in research and development are expected to restrain the growth of this market during the forecast period.

The cell therapies segment accounted for the highest growth rate in the regenerative medicine market, by product, during the forecast period

Based on products, the regenerative medicine market is segmented into tissue-engineered products, cell therapies, gene therapies, and progenitor and stem cell therapies. The cell therapies segment accounted for the highest growth rate in the regenerative medicine market in 2019. The increasing adoption of tissue-engineered products for the treatment of chronic wounds and musculoskeletal disorders and the rising funding for the R&D of regenerative medicine products and therapies are the major factors driving the growth of this segment.

Oncology segment accounted for highest CAGR

Based on applications, the regenerative medicine market is segmented into musculoskeletal disorders, wound care, oncology, ocular disorders, dental, and other applications. In 2019, the oncology segment accounted for the highest growth rate. This can be attributed to the rising prevalence of orthopedic diseases, growing geriatric population, increasing number of stem cell research projects, growing number of clinical researches/trials, and the rich pipeline of stem cell products for the treatment of musculoskeletal disorders.

Europe: The fastest-growing region regenerative medicine market

The global regenerative medicine market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. The North America region is projected to grow at the highest CAGR during the forecast period in 2019. The growth in the North American regenerative medicine market can be attributed to rising stem cell banking, tissue engineering, and drug discovery in the region; expansion of the healthcare sector; and the high adoption of stem cell therapy and cell immunotherapies for the treatment of cancer and chronic diseases.

Market Dynamics

Drivers

  • Rising Prevalence of Chronic Diseases, Genetic Disorders, and Cancer
  • Rising Investments in Regenerative Medicine Research
  • Growing Pipeline of Regenerative Medicine Products

Restraints

  • Ethical Concerns Related to the Use of Embryonic Stem Cells in Research & Development
  • High Cost of Cell and Gene Therapies

Opportunities

  • Implementation of the 21st Century Cures Act
  • Rising Demand for Organ Transplantations

Impact of the COVID-19 Pandemic on the Regenerative Medicine Market

Companies Mentioned

  • 3M Group
  • Allergan
  • Amgen, Inc.
  • Anterogen Co., Ltd.
  • APAC Biotech
  • Aspect Biosystems
  • Bluebird Bio
  • Corestem, Inc.
  • Integra Lifesciences Holdings Corporation
  • Kite Pharma
Read more

Global Regenerative Medicine Market 2020-2025: Opportunities with the Implementation of the 21st Century Cures Act – Press Release

Dublin, Nov. 24, 2020 (GLOBE NEWSWIRE) — The “Regenerative Medicine Market by Product (Cell Therapies (Autologous, Allogenic), Stemcell Therapy, Tissue-engineering, Gene Therapy), Application (Wound Care, Musculoskeletal, Oncology, Dental, Ocular), Geography – Global Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering.

The Global Regenerative Medicine Market is Projected to Reach USD 17.9 Billion by 2025 from USD 8.5 Billion in 2020, at a CAGR of 15.9% during the Forecast Period.

Market growth is driven by the rising prevalence of chronic diseases, genetic disorders, and cancer; rising investments in regenerative medicine research; and the growing pipeline of regenerative medicine products. However, the high cost of cell and gene therapies and ethical concerns related to the use of embryonic stem cells in research and development are expected to restrain the growth of this market during the forecast period.

The cell therapies segment accounted for the highest growth rate in the regenerative medicine market, by product, during the forecast period

Based on products, the regenerative medicine market is segmented into tissue-engineered products, cell therapies, gene therapies, and progenitor and stem cell therapies. The cell therapies segment accounted for the highest growth rate in the regenerative medicine market in 2019. The increasing adoption of tissue-engineered products for the treatment of chronic wounds and musculoskeletal disorders and the rising funding for the R&D of regenerative medicine products and therapies are the major factors driving the growth of this segment.

Oncology segment accounted for highest CAGR

Based on applications, the regenerative medicine market is segmented into musculoskeletal disorders, wound care, oncology, ocular disorders, dental, and other applications. In 2019, the oncology segment accounted for the highest growth rate. This can be attributed to the rising prevalence of orthopedic diseases, growing geriatric population, increasing number of stem cell research projects, growing number of clinical researches/trials, and the rich pipeline of stem cell products for the treatment of musculoskeletal disorders.

Europe: The fastest-growing region regenerative medicine market

The global regenerative medicine market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. The North America region is projected to grow at the highest CAGR during the forecast period in 2019. The growth in the North American regenerative medicine market can be attributed to rising stem cell banking, tissue engineering, and drug discovery in the region; expansion of the healthcare sector; and the high adoption of stem cell therapy and cell immunotherapies for the treatment of cancer and chronic diseases.

Market Dynamics

Drivers

  • Rising Prevalence of Chronic Diseases, Genetic Disorders, and Cancer
  • Rising Investments in Regenerative Medicine Research
  • Growing Pipeline of Regenerative Medicine Products

Restraints

  • Ethical Concerns Related to the Use of Embryonic Stem Cells in Research & Development
  • High Cost of Cell and Gene Therapies

Opportunities

  • Implementation of the 21st Century Cures Act
  • Rising Demand for Organ Transplantations

Impact of the COVID-19 Pandemic on the Regenerative Medicine Market

Companies Mentioned

  • 3M Group
  • Allergan
  • Amgen, Inc.
  • Anterogen Co., Ltd.
  • APAC Biotech
  • Aspect Biosystems
  • Bluebird Bio
  • Corestem, Inc.
  • Integra Lifesciences Holdings Corporation
  • Kite Pharma
  • Medipost
Read more

Aesthetic Medicine and Cosmetics Market 2020 Global Analysis, Opportunities And Forecast to 2025

“Aesthetic Medicine and Cosmetics Market”

Wiseguyreports.Com Adds “Aesthetic Medicine and Cosmetics -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2025” To Its Research Database

Aesthetic Medicine and Cosmetics Industry

Description

Wiseguyreports.Com Adds “Aesthetic Medicine and Cosmetics -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2025” To Its Research Database

The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Aesthetic Medicine and Cosmetics by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

This report contains opportunities, strengths, threats, and weaknesses (SWOT) analysis for this market. They have taken many aspects into account for analysis, including sales volume, revenue level of the last few years, product demands, customer retention, etc. A majority of information has been collected from primary sources, and analysts have taken effective samples. As the market size is large, analysts have taken large sample sizes from different regions of the globe. They also calculated the Aesthetic Medicine and Cosmetics Market’s customer churns level because it plays a vital role in sales volume. This research analysis report can help this Aesthetic Medicine and Cosmetics Market to become sustainable in the market from a global context.

Request For Sample Report @ https://www.wiseguyreports.com/sample-request/5043846-global-aesthetic-medicine-and-cosmetics-market-analysis-2015

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):

NuYu Medispa
Al Qamra Holding Group
Premium Naseem
Dr. Makki Plastic Surgicentre
Medica Group
Silkor
Al Emadi Hospital

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Surgical Procedures
Non-Surgical Procedures

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospitals & Clinics
Beauty Centers & Medical Spas
Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)

Leave a Query @ https://www.wiseguyreports.com/enquiry/5043846-global-aesthetic-medicine-and-cosmetics-market-analysis-2015

 

Table of Contents

1 Industry Overview
1.1 Aesthetic Medicine and Cosmetics Industry
Figure Aesthetic Medicine and Cosmetics Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Aesthetic Medicine and Cosmetics
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Aesthetic Medicine and Cosmetics
1.2.2 Downstream
Table Application Segment of Aesthetic Medicine and Cosmetics
Table Global Aesthetic Medicine and Cosmetics Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis

2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology

….

4 Major Companies List
4.1 NuYu Medispa (Company Profile, Sales Data etc.)
4.1.1 NuYu Medispa Profile
Table NuYu Medispa Overview List
4.1.2 NuYu Medispa Products & Services
4.1.3 NuYu Medispa Business Operation Conditions
Table Business Operation of NuYu Medispa (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Al Qamra Holding Group (Company Profile, Sales Data etc.)
4.2.1 Al Qamra Holding Group Profile
Table Al

Read more

Perils and Opportunities of a Public Option

By Lanhee J. Chen and Daniel L. HeilOct. 19, 2020 6:59 pm ETJoe Biden campaigns in Pembroke Pines, Fla., Oct. 13.



Photo:

Chip Somodevilla/Getty Images

Regarding Lanhee J. Chen and Daniel L. Heil’s “Biden’s Public Option Would Mean Massive Tax Hikes,” op-ed, Oct. 20): Any vast expansion of government health insurance for “all” is at a minimum evidence that ObamaCare has failed to deliver as advertised. Massive expansion of spending would disable health care and government generally. The obvious fact that ObamaCare hasn’t delivered hardly provides evidence that much more government will rescue the system. It is past time to try much less government, more freedom and many more choices for the large number of us not liberated by ObamaCare. If it has done the job, what is the debate about?

Richard E. Ralston

Executive Director, Americans for Free Choice in Medicine

Newport Beach, Calif.

Employer-paid health insurance finances a health-insurance industry which adds little or no net value to the economy. Way too high a proportion of health-care costs goes to administration. Let the dead 1940s idea of employer-paid health insurance gracefully pass away with the single-payer public option.

Steven Williams

Pittsburgh

It’s ironic politicians define a public option to health care as one determined and rationed by the government. A true “public” option would allow individuals to decide what is best for them and where to spend their health-care dollars. All that would require is a transparent price and a system more aligned with patient needs.

Paula Muto, M.D., FACS

Andover, Mass.

Copyright ©2020 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Appeared in the October 26, 2020, print edition.

Source Article

Read more

Galacto-oligosaccharide Market | Europe to Present Significant Growth Opportunities Through 2024

The global galacto-oligosaccharide market is expected to grow by USD 486.79 million as per Technavio’s market research report. The analysis of the impact of COVID-19 on the market reveals a market slowdown in the first half of 2020,. However, the effect will gradually lessen in the coming quarters. In addition, steady growth is expected to continue throughout the forecast period, and the market is expected to grow at a CAGR of 10%. . Request Free Sample Report on COVID-19 Impacts

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201020005537/en/

Technavio has announced its latest market research report titled Global Galacto-oligosaccharide Market 2020-2024 (Graphic: Business Wire)

Read the 120-page report with TOC on “Galacto-oligosaccharide Market Analysis Report by Product (Syrup and Powder), Geography (Europe, North America, Asia, and ROW), and the Segment Forecasts, 2020-2024”. https://www.technavio.com/report/galacto-oligosaccharide-market-size-industry-analysis

The market is driven by the health benefits of galacto-oligosaccharides. In addition, the use of nutraceuticals and prebiotics in treating chronic diseases is anticipated to boost the growth of the galacto-oligosaccharide market.

Galacto-oligosaccharides are prebiotics and non-digestible food ingredients. They stimulate the activity of gut bacteria, which improves immunity, enhance the absorption of essential nutrients, and produce powerful antioxidant H2 gas. Galacto-oligosaccharides also inhibit the binding or survival of opportunistic microorganisms, such as Escherichia coli, Salmonella Typhimurium, and Clostridia. They can also influence the immune system by producing antimicrobial substances and inhibit the growth of pathogenic bacteria. Many such health benefits are fueling the growth of the global galacto-oligosaccharide market.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Major Five Galacto-oligosaccharide Companies:

Clasado Biosciences

Clasado Biosciences operates its business through a unified segment. The company offers Bimuno, which is a daily fiber supplement containing galacto-oligosaccharides, which feeds and stimulates the growth of good bacteria in the gut.

Fonterra Co operative Group Ltd.

Fonterra Co operative Group Ltd. operates its business through segments such as Ingredients, Consumer and foodservice, and China Farms. The company offers NZMP SureStart GOS, which is a prebiotic supplement added to infant formula products to make them closer to the composition of breast milk for mothers who cannot or choose not to breastfeed.

Ingredion Inc.

Ingredion Inc. operates its business through segments such as North America, South America, Asia Pacific, and EMEA. The company offers BIOLIGO GL 5700 IMF. It is a soluble dietary fiber made from lactose in the form of a syrup that contains 57% galacto-oligosaccharide.

Lactose (India) Ltd.

Lactose (India) Ltd. operates its business through a unified segment. The company offers galacto-oligosaccharide produced through the enzymatic conversion of lactose and is available in the powder form.

New Francisco (Yunfu City) Biotechnology Corp. Ltd.

New Francisco (Yunfu City) Biotechnology Corp. Ltd. operates its business through a unified segment. The company offers products such as GOS-270-P, GOS-700-P, and GOS-800-P.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio’s SUBSCRIPTION platform

Galacto-oligosaccharide Market Product Outlook (Revenue,

Read more
  • Partner links